Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

BCPC vs LIN

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
BCPC
Balchem Corporation

Chemicals - Specialty

Basic MaterialsNASDAQ • US
Market Cap$5.17B
5Y Perf.+60.3%
LIN
Linde plc

Chemicals - Specialty

Basic MaterialsNASDAQ • GB
Market Cap$232.56B
5Y Perf.+148.0%

BCPC vs LIN — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
BCPC logoBCPC
LIN logoLIN
IndustryChemicals - SpecialtyChemicals - Specialty
Market Cap$5.17B$232.56B
Revenue (TTM)$1.06B$34.66B
Net Income (TTM)$158M$7.13B
Gross Margin36.3%46.0%
Operating Margin21.0%28.8%
Forward P/E31.2x28.1x
Total Debt$192M$26.99B
Cash & Equiv.$75M$5.06B

BCPC vs LINLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

BCPC
LIN
StockMay 20May 26Return
Balchem Corporation (BCPC)100160.3+60.3%
Linde plc (LIN)100248.0+148.0%

Price return only. Dividends and distributions are not included.

Quick Verdict: BCPC vs LIN

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: LIN leads in 4 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. Balchem Corporation is the stronger pick specifically for growth and revenue expansion and dividend income and shareholder returns. As sector peers, any of these can serve as alternatives in the same allocation.
BCPC
Balchem Corporation
The Growth Play

BCPC is the clearest fit if your priority is growth exposure and sleep-well-at-night.

  • Rev growth 8.8%, EPS growth 20.9%, 3Y rev CAGR 3.2%
  • Lower volatility, beta 0.33, Low D/E 15.3%, current ratio 2.07x
  • 8.8% revenue growth vs LIN's 3.0%
Best for: growth exposure and sleep-well-at-night
LIN
Linde plc
The Income Pick

LIN carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • Dividend streak 6 yrs, beta 0.24, yield 1.2%
  • 376.9% 10Y total return vs BCPC's 162.8%
  • PEG 1.11 vs BCPC's 2.44
Best for: income & stability and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthBCPC logoBCPC8.8% revenue growth vs LIN's 3.0%
ValueLIN logoLINLower P/E (28.1x vs 31.2x), PEG 1.11 vs 2.44
Quality / MarginsLIN logoLIN20.6% margin vs BCPC's 15.0%
Stability / SafetyLIN logoLINBeta 0.24 vs BCPC's 0.33
DividendsBCPC logoBCPC0.5% yield, 11-year raise streak, vs LIN's 1.2%
Momentum (1Y)LIN logoLIN+13.6% vs BCPC's -0.8%
Efficiency (ROA)BCPC logoBCPC9.4% ROA vs LIN's 8.3%, ROIC 12.2% vs 11.3%

BCPC vs LIN — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

BCPCBalchem Corporation
FY 2025
Product Sales
99.8%$1.0B
Royalty
0.2%$2M
LINLinde plc
FY 2025
Americas Segment
45.9%$15.2B
EMEA Segment
25.8%$8.5B
APAC Segment
20.1%$6.7B
Engineering Segment
8.2%$2.7B

BCPC vs LIN — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLLINLAGGINGBCPC

Income & Cash Flow (Last 12 Months)

LIN leads this category, winning 5 of 6 comparable metrics.

LIN is the larger business by revenue, generating $34.7B annually — 32.8x BCPC's $1.1B. LIN is the more profitable business, keeping 20.6% of every revenue dollar as net income compared to BCPC's 15.0%.

MetricBCPC logoBCPCBalchem Corporati…LIN logoLINLinde plc
RevenueTrailing 12 months$1.1B$34.7B
EBITDAEarnings before interest/tax$267M$12.1B
Net IncomeAfter-tax profit$158M$7.1B
Free Cash FlowCash after capex$182M$5.1B
Gross MarginGross profit ÷ Revenue+36.3%+46.0%
Operating MarginEBIT ÷ Revenue+21.0%+28.8%
Net MarginNet income ÷ Revenue+15.0%+20.6%
FCF MarginFCF ÷ Revenue+17.2%+14.7%
Rev. Growth (YoY)Latest quarter vs prior year+8.1%+8.2%
EPS Growth (YoY)Latest quarter vs prior year+10.6%+13.4%
LIN leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

BCPC leads this category, winning 4 of 7 comparable metrics.

At 34.0x trailing earnings, BCPC trades at a 1% valuation discount to LIN's 34.4x P/E. Adjusting for growth (PEG ratio), LIN offers better value at 1.36x vs BCPC's 2.65x — a lower PEG means you pay less per unit of expected earnings growth.

MetricBCPC logoBCPCBalchem Corporati…LIN logoLINLinde plc
Market CapShares × price$5.2B$232.6B
Enterprise ValueMkt cap + debt − cash$5.3B$254.5B
Trailing P/EPrice ÷ TTM EPS33.97x34.40x
Forward P/EPrice ÷ next-FY EPS est.31.23x28.12x
PEG RatioP/E ÷ EPS growth rate2.65x1.36x
EV / EBITDAEnterprise value multiple20.06x20.04x
Price / SalesMarket cap ÷ Revenue4.98x6.84x
Price / BookPrice ÷ Book value/share4.18x5.92x
Price / FCFMarket cap ÷ FCF29.86x45.70x
BCPC leads this category, winning 4 of 7 comparable metrics.

Profitability & Efficiency

BCPC leads this category, winning 7 of 9 comparable metrics.

LIN delivers a 17.8% return on equity — every $100 of shareholder capital generates $18 in annual profit, vs $12 for BCPC. BCPC carries lower financial leverage with a 0.15x debt-to-equity ratio, signaling a more conservative balance sheet compared to LIN's 0.68x. On the Piotroski fundamental quality scale (0–9), BCPC scores 9/9 vs LIN's 6/9, reflecting strong financial health.

MetricBCPC logoBCPCBalchem Corporati…LIN logoLINLinde plc
ROE (TTM)Return on equity+12.4%+17.8%
ROA (TTM)Return on assets+9.4%+8.3%
ROICReturn on invested capital+12.2%+11.3%
ROCEReturn on capital employed+14.8%+13.0%
Piotroski ScoreFundamental quality 0–996
Debt / EquityFinancial leverage0.15x0.68x
Net DebtTotal debt minus cash$117M$21.9B
Cash & Equiv.Liquid assets$75M$5.1B
Total DebtShort + long-term debt$192M$27.0B
Interest CoverageEBIT ÷ Interest expense15.23x34.52x
BCPC leads this category, winning 7 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

LIN leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in LIN five years ago would be worth $17,813 today (with dividends reinvested), compared to $12,441 for BCPC. Over the past 12 months, LIN leads with a +13.6% total return vs BCPC's -0.8%. The 3-year compound annual growth rate (CAGR) favors LIN at 12.4% vs BCPC's 8.6% — a key indicator of consistent wealth creation.

MetricBCPC logoBCPCBalchem Corporati…LIN logoLINLinde plc
YTD ReturnYear-to-date+4.8%+17.3%
1-Year ReturnPast 12 months-0.8%+13.6%
3-Year ReturnCumulative with dividends+28.0%+41.9%
5-Year ReturnCumulative with dividends+24.4%+78.1%
10-Year ReturnCumulative with dividends+162.8%+376.9%
CAGR (3Y)Annualised 3-year return+8.6%+12.4%
LIN leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

LIN leads this category, winning 2 of 2 comparable metrics.

LIN is the less volatile stock with a 0.24 beta — it tends to amplify market swings less than BCPC's 0.33 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LIN currently trades 96.3% from its 52-week high vs BCPC's 87.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricBCPC logoBCPCBalchem Corporati…LIN logoLINLinde plc
Beta (5Y)Sensitivity to S&P 5000.33x0.24x
52-Week HighHighest price in past year$183.90$521.28
52-Week LowLowest price in past year$139.17$387.78
% of 52W HighCurrent price vs 52-week peak+87.8%+96.3%
RSI (14)Momentum oscillator 0–10032.350.6
Avg Volume (50D)Average daily shares traded189K2.3M
LIN leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Evenly matched — BCPC and LIN each lead in 1 of 2 comparable metrics.

Wall Street rates BCPC as "Buy" and LIN as "Buy". Consensus price targets imply 7.5% upside for LIN (target: $540) vs 0.4% for BCPC (target: $162). For income investors, LIN offers the higher dividend yield at 1.20% vs BCPC's 0.54%.

MetricBCPC logoBCPCBalchem Corporati…LIN logoLINLinde plc
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$162.00$539.71
# AnalystsCovering analysts1028
Dividend YieldAnnual dividend ÷ price+0.5%+1.2%
Dividend StreakConsecutive years of raises116
Dividend / ShareAnnual DPS$0.87$6.00
Buyback YieldShare repurchases ÷ mkt cap+2.1%+2.0%
Evenly matched — BCPC and LIN each lead in 1 of 2 comparable metrics.
Key Takeaway

LIN leads in 3 of 6 categories (Income & Cash Flow, Total Returns). BCPC leads in 2 (Valuation Metrics, Profitability & Efficiency). 1 tied.

Best OverallLinde plc (LIN)Leads 3 of 6 categories
Loading custom metrics...

BCPC vs LIN: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is BCPC or LIN a better buy right now?

For growth investors, Balchem Corporation (BCPC) is the stronger pick with 8.

8% revenue growth year-over-year, versus 3. 0% for Linde plc (LIN). Balchem Corporation (BCPC) offers the better valuation at 34. 0x trailing P/E (31. 2x forward), making it the more compelling value choice. Analysts rate Balchem Corporation (BCPC) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — BCPC or LIN?

On trailing P/E, Balchem Corporation (BCPC) is the cheapest at 34.

0x versus Linde plc at 34. 4x. On forward P/E, Linde plc is actually cheaper at 28. 1x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Linde plc wins at 1. 11x versus Balchem Corporation's 2. 44x — a reasonable growth-adjusted valuation.

03

Which is the better long-term investment — BCPC or LIN?

Over the past 5 years, Linde plc (LIN) delivered a total return of +78.

1%, compared to +24. 4% for Balchem Corporation (BCPC). Over 10 years, the gap is even starker: LIN returned +376. 9% versus BCPC's +162. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — BCPC or LIN?

By beta (market sensitivity over 5 years), Linde plc (LIN) is the lower-risk stock at 0.

24β versus Balchem Corporation's 0. 33β — meaning BCPC is approximately 37% more volatile than LIN relative to the S&P 500. On balance sheet safety, Balchem Corporation (BCPC) carries a lower debt/equity ratio of 15% versus 68% for Linde plc — giving it more financial flexibility in a downturn.

05

Which is growing faster — BCPC or LIN?

By revenue growth (latest reported year), Balchem Corporation (BCPC) is pulling ahead at 8.

8% versus 3. 0% for Linde plc (LIN). On earnings-per-share growth, the picture is similar: Balchem Corporation grew EPS 20. 9% year-over-year, compared to 7. 1% for Linde plc. Over a 3-year CAGR, BCPC leads at 3. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — BCPC or LIN?

Linde plc (LIN) is the more profitable company, earning 20.

3% net margin versus 14. 9% for Balchem Corporation — meaning it keeps 20. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LIN leads at 26. 3% versus 21. 1% for BCPC. At the gross margin level — before operating expenses — LIN leads at 43. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is BCPC or LIN more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Linde plc (LIN) is the more undervalued stock at a PEG of 1. 11x versus Balchem Corporation's 2. 44x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Linde plc (LIN) trades at 28. 1x forward P/E versus 31. 2x for Balchem Corporation — 3. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for LIN: 7. 5% to $539. 71.

08

Which pays a better dividend — BCPC or LIN?

All stocks in this comparison pay dividends.

Linde plc (LIN) offers the highest yield at 1. 2%, versus 0. 5% for Balchem Corporation (BCPC).

09

Is BCPC or LIN better for a retirement portfolio?

For long-horizon retirement investors, Linde plc (LIN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

24), 1. 2% yield, +376. 9% 10Y return). Both have compounded well over 10 years (LIN: +376. 9%, BCPC: +162. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between BCPC and LIN?

Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

BCPC

Stable Dividend Mega-Cap

  • Sector: Basic Materials
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 8%
Run This Screen
Stocks Like

LIN

Quality Mega-Cap Compounder

  • Sector: Basic Materials
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 12%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform BCPC and LIN on the metrics below

Revenue Growth>
%
(BCPC: 8.1% · LIN: 8.2%)
Net Margin>
%
(BCPC: 15.0% · LIN: 20.6%)
P/E Ratio<
x
(BCPC: 34.0x · LIN: 34.4x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.